BA-004
bioAffinity Technologies Inc.
bioAffinity Technologies Inc.
Asan Medical Center
West China Hospital
Peking University First Hospital
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Dokuz Eylul University
Dana-Farber Cancer Institute
Sun Yat-sen University
Zhejiang University
University of Eastern Finland
Essen Biotech
University of Vienna
The First Affiliated Hospital of Xiamen University
University of Chicago
Clinique Paris-Bercy
Osijek University Hospital
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Cedars-Sinai Medical Center
Tseung Kwan O Hospital, Hong Kong
Chung Shan Medical University
Université Catholique de Louvain
Royal Marsden NHS Foundation Trust
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Ezisurg Medical Co. Ltd.
University Hospital, Brest
Cosmetique Active International
Tri-Service General Hospital
Nantes University Hospital
Peking University First Hospital
Leiden University Medical Center
Istanbul University
University of Rochester
University of Florida
Shanghai Chest Hospital
Johns Hopkins University
Memorial Sloan Kettering Cancer Center
Peter MacCallum Cancer Centre, Australia
University of California, San Francisco
Gadjah Mada University
Xijing Hospital
University of Texas Southwestern Medical Center
Xijing Hospital
Peking University First Hospital
Zhejiang University
Delfi Diagnostics Inc.
Anbogen Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
TOLREMO therapeutics AG
Tongji Hospital